Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain

Cristina D. Peterson, Kelley F. Kitto, Harsha Verma, Kelsey Pflepsen, Eric Delpire, George L. Wilcox, Carolyn A. Fairbanks

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain'. Together they form a unique fingerprint.

Medicine & Life Sciences